CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $74,198
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$74,198. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-10-08 | BROADWOOD PARTNERS LP Director | Other acquisition | +4,040,523 | $3.12 | $12.6M | 17,832,785 |
| 2014-10-08 | BROADWOOD PARTNERS LP Director | Other acquisition | +0 | 17,832,785 | ||
| 2014-07-22 | BROADWOOD PARTNERS LP Director | Purchase | +100,000 | $2.65 | $265K | 13,522,262 |
| 2014-07-22 | BROADWOOD PARTNERS LP Director | Purchase | +0 | 13,522,262 | ||
| 2014-07-22 | BROADWOOD PARTNERS LP Director | Purchase | +270,000 | $2.65 | $716K | 13,792,262 |
| 2014-07-22 | BROADWOOD PARTNERS LP Director | Purchase | +0 | 13,792,262 | ||
| 2014-07-22 | Peabody Robert Sr. VP, COO, and CFO | Sale | −100,000 | $2.65 | $265K | 315,777 |
| 2014-07-22 | WEST MICHAEL D Chief Executive Officer | Sale | −270,000 | $2.65 | $716K | 875,987 |
| 2014-07-21 | Peabody Robert Sr. VP, COO, and CFO | Exercise or conversion | +475,000 | $0.50 | $238K | 505,400 |
| 2014-07-21 | Peabody Robert Sr. VP, COO, and CFO | Shares withheld for taxes | −89,623 | $2.65 | $238K | 415,777 |
| 2014-07-21 | Peabody Robert Sr. VP, COO, and CFO | Exercise or conversion · Option to Purchase Common Shares | −475,000 | 0 | ||
| 2014-07-21 | WEST MICHAEL D Chief Executive Officer | Exercise or conversion | +1,470,400 | $0.50 | $735K | 1,580,000 |
| 2014-07-21 | WEST MICHAEL D Chief Executive Officer | Shares withheld for taxes | −434,013 | $2.65 | $1.2M | 1,145,987 |
| 2014-07-21 | WEST MICHAEL D Chief Executive Officer | Exercise or conversion · Option to Purchase Common Shares | −1,470,400 | 0 | ||
| 2014-07-01 | SCHLACHET DAVID Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2014-07-01 | SCHLACHET DAVID Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2014-07-01 | LICHTINGER PEDRO Director | Grant or award · option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2014-07-01 | KINGSLEY ALFRED D Director | Grant or award · Option to Purchase Common Shares | +50,000 | 50,000 | ||
| 2014-07-01 | FARRELL STEPHEN C Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2014-07-01 | ANDREWS DEBORAH J Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 |
Page 20 of 24 · 472 trades